Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
Alain H. Rook, Joel M. Gelfand, Maria Wysocka, et al.
Blood (2015) Vol. 126, Iss. 12, pp. 1452-1461
Open Access | Times Cited: 197

Showing 1-25 of 197 citing articles:

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich, Thomas U. Marron, Ranjan Upadhyay, et al.
Nature Medicine (2019) Vol. 25, Iss. 5, pp. 814-824
Closed Access | Times Cited: 362
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero, Eduardo Castañón, Maite Álvarez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 558-576
Open Access | Times Cited: 341
Intratumoral immunotherapy: using the tumor as the remedy
Aurélien Marabelle, Lambros Tselikas, Thierry de Baère, et al.
Annals of Oncology (2017) Vol. 28, pp. xii33-xii43
Open Access | Times Cited: 306
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
Chun Gwon Park, Christina Hartl, Daniela Schmid, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 433
Open Access | Times Cited: 282
The Role of Macrophages in Cancer Development and Therapy
Ewa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1946-1946
Open Access | Times Cited: 248
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
Katelyn T. Byrne, Robert H. Vonderheide
Cell Reports (2016) Vol. 15, Iss. 12, pp. 2719-2732
Open Access | Times Cited: 244
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Stefanie Mullins, John P. Vasilakos, Katharina Deschler, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 153
Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
Claire Vanpouille‐Box, Jules A. Hoffmann, Lorenzo Galluzzi
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 11, pp. 845-867
Closed Access | Times Cited: 147
Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice
Julia Wagner, Dorothée Gößl, Natasha Ustyanovska Avtenyuk, et al.
ACS Nano (2021) Vol. 15, Iss. 3, pp. 4450-4466
Open Access | Times Cited: 131
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications
Sahar Sedighzadeh, Amin Pastaki Khoshbin, Sepideh Razi, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 4, pp. 1889-1916
Open Access | Times Cited: 124
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 124
The Impact of Prolonged Inflammation on Wound Healing
Judith C. J. Holzer-Geissler, Simon Schwingenschuh, Martin Zacharias, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 856-856
Open Access | Times Cited: 103
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 66
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 61
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
Huju Chi, Chunman Li, Flora Sha Zhao, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 161
White paper on microbial anti-cancer therapy and prevention
Neil S. Forbes, Robert S. Coffin, Liang Deng, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 141
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
Bayard R. Huck, Lisa Kötzner, Klaus Urbahns
Angewandte Chemie International Edition (2017) Vol. 57, Iss. 16, pp. 4412-4428
Open Access | Times Cited: 133
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2019) Vol. 94, Iss. 9, pp. 1027-1041
Open Access | Times Cited: 117
High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides
Adèle de Masson, John T. O’Malley, Christopher P. Elco, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 440
Open Access | Times Cited: 111
Intratumoral Immunotherapy: From Trial Design to Clinical Practice
Stéphane Champiat, Lambros Tselikas, Siham Farhane, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 3, pp. 665-679
Open Access | Times Cited: 108
The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
William G. Kerr, John D. Chisholm
The Journal of Immunology (2018) Vol. 202, Iss. 1, pp. 11-19
Open Access | Times Cited: 105
Targeting Toll-Like Receptors for Cancer Therapy
Marc J. Braunstein, John Kucharczyk, Sylvia Adams
Targeted Oncology (2018) Vol. 13, Iss. 5, pp. 583-598
Closed Access | Times Cited: 98
An overview of cutaneous T cell lymphomas
Nooshin Bagherani, Bruce R. Smoller
F1000Research (2016) Vol. 5, pp. 1882-1882
Open Access | Times Cited: 97
Page 1 - Next Page

Scroll to top